Compounds > esreboxetine
Page last updated: 2024-08-24

esreboxetine and Fibromyalgia

esreboxetine has been researched along with Fibromyalgia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, LM; Chatamra, K; Hirsch, I; Stoker, M1
Arnold, LM; Ellis, A; Hirsch, I; Hughes, B; Sanders, P1

Trials

2 trial(s) available for esreboxetine and Fibromyalgia

ArticleYear
Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study.
    Clinical therapeutics, 2010, Volume: 32, Issue:9

    Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Double-Blind Method; Fatigue; Female; Fibromyalgia; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Pain Measurement; Quality of Life; Treatment Outcome; Young Adult

2010
Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Arthritis and rheumatism, 2012, Volume: 64, Issue:7

    Topics: Adult; Aged; Double-Blind Method; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Morpholines; Pain; Pain Measurement; Patient Satisfaction; Severity of Illness Index; Treatment Outcome

2012